mHealth App for Psychosis
Trial Summary
What is the purpose of this trial?
The proposed study research project aims to develop and test a mobile health intervention designed to improve the wellness of young people at risk for psychosis and facilitate users' engagement with treatment and thus reduce duration of untreated psychosis. This clinical trial will involve a remote pilot randomized controlled trial that will examine (1) the feasibility of the proposed research approach, (2) the acceptability and usability of the NORTH intervention as well as (3) the specific additive value of help-seeking support in the context of self-guided mHealth for early psychosis. The full intervention, which includes psychoeducational lessons, Cognitive-Behavior Therapy-based practices, a symptom tracking feature, and help-seeking resources will be compared to a "Lite" version that will include the lessons, practices, and tracking but exclude the help-seeking resources.
Do I have to stop taking my current medications to join the trial?
The trial requires that you have not taken a prescribed antipsychotic medication in the past three months. If you are currently taking such medication, you would not be eligible to participate.
What data supports the idea that mHealth App for Psychosis (also known as: NORTH) is an effective treatment?
The available research shows that using smartphone apps for psychosis treatment is promising. One study found that integrating a smartphone app into early psychosis care is feasible and provides symptom data similar to traditional clinician assessments. Another study highlighted the potential benefits of a smartphone app for managing early psychosis, suggesting it could be a useful tool. Additionally, a study on a similar app for schizophrenia-spectrum disorders showed significant reductions in psychiatric symptoms and improved coping strategies over a month. These findings suggest that mHealth apps can be effective in managing psychosis symptoms and supporting recovery.12345
What safety data exists for the mHealth app for psychosis?
The research indicates that mHealth interventions for psychosis, including those using mobile phones, are generally feasible, acceptable, and clinically promising. However, specific safety data for the mHealth app for psychosis, potentially evaluated under the name NORTH, is not directly mentioned in the provided studies. The studies focus on the accessibility, usability, and engagement of mHealth apps for psychosis, but do not provide detailed safety data. Further research or specific clinical trials would be needed to assess the safety of this particular app.36789
Is the treatment NORTH a promising treatment for psychosis?
Yes, the mHealth app for psychosis, which includes the treatment NORTH, is promising because it offers accessible, low-cost support through smartphones. It helps with self-management, encourages help-seeking, and provides information on medications, stress management, and symptom tracking. This makes it appealing to young adults with early psychosis and can improve recovery and treatment outcomes.348910
Research Team
Benjamin Buck, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for young adults aged 18-30 in the U.S. who are at risk for psychosis but haven't been treated with antipsychotic meds or regular psychotherapy recently. They must own an iPhone and be within five years of their first psychotic episode or symptom onset.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- NORTH
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator